Datos del evento
Av. Diagonal 547, 08029 Barcelona (España)
Organized by MDPI, the publisher of the open-access journal Molecules, this conference follows the successful MMCS2019 and MMCS2022 editions, maintaining the highly appreciated three-day format to accommodate a diverse range of contributions and a large audience interested in the impact that the emergence of new drug modalities is having in drug discovery. MMCS2024’s thematic sessions will revolve around photoactivatable drugs, candidates that hit RNA and epigenetic targets, and covalent modifiers. The use of these and other more classical approaches for the development of new anti-cancer agents and other medicinal chemistry projects will also be covered.
Each session will include two distinguished invited speakers, who will share their insights alongside selected oral communications. Poster presentations and social events will further enrich the program.
We look forward to welcoming you to Barcelona in April, a perfect time to visit for its delightful weather, vibrant spring atmosphere, and wide array of cultural and outdoor activities that will provide an inspiring backdrop for our conference.